FDA Adverse Event Injury Summary report: N

EASYTRAK 2

MDR report key: 3241504 · Received July 22, 2013

Report

Report Number
2124215-2013-11170
Event Type
Injury
Date Received
July 22, 2013
Date of Event
May 17, 2013
Report Date
May 17, 2013
Manufacturer
CPI - DEL CARIBE
Product Code
OJX
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
NJ
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

UPON RECEIPT AT OUR POST MARKET QUALITY ASSURANCE LABORATORY, VISUAL OBSERVATION REVEALED DRIED BLOOD/BLOODY FLUID IN THE LEAD LUMEN. ALLEGATION OF DIAPHRAGMATIC STIMULATION AND DISLODGEMENT NOT CONFIRMED VISUALLY.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT THAT THIS LEFT VENTRICULAR (LV) LEAD HAD DISLODGED LITTLE WHICH PROBABLY CAUSED THE DIAPHRAGMATIC STIMULATION THAT THE PATIENT HAS BEEN FEELING. THIS LEAD WAS EXPLANTED AND RETURNED. ADDITIONAL INFORMATION RECEIVED CONFIRMING THE MUSCLE STIMULATION IN ALL CONFIGURATION BROUGHT ABOUT BY MICRODISLODGEMENT OF THE LV LEAD. NO ADVERSE PATIENT EFFECTS WERE REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
340970 EASYTRAK 2 IMPLANTABLE LEAD OJX CPI - DEL CARIBE 4543

Patients

Seq Age Sex Outcome Treatment
1 57 YR Hospitalization| L| R 4136| 4137| V173| 4555| 4543